PTE logo

PolarityTE (PTE) Stock

Profile

Full Name:

PolarityTE, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

16 August 1999

Indexes:

Not included

Description:

PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 10, 2021

Recent annual earnings:

Mar 30, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Jan 12, 2016
Splits

Next split:

N/A

Recent split:

May 17, 2022

Analyst ratings

Recent major analysts updates

28 Dec '22 Northland Capital Markets
Outperform
12 May '20 Cantor Fitzgerald
Overweight
04 May '20 HC Wainwright & Co.
Neutral
13 Nov '19 Piper Jaffray
Overweight
11 Nov '19 Cantor Fitzgerald
Overweight
08 July '19 H.C. Wainwright
Buy
29 Jan '19 Oppenheimer
Outperform
28 Jan '19 Northland Securities
Outperform
28 Jan '19 National Securities
Sell
20 Dec '18 PiperJaffray
Overweight

Screeners with PTE included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

PolarityTE, Inc. (PTE) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
PolarityTE, Inc. (PTE) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
PolarityTE, Inc. (PTE) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
PTE
Zacks Investment Research25 April 2023

PolarityTE, Inc. (PTE) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

FAQ

  • What is the primary business of PolarityTE?
  • What is the ticker symbol for PolarityTE?
  • Does PolarityTE pay dividends?
  • What sector is PolarityTE in?
  • What industry is PolarityTE in?
  • What country is PolarityTE based in?
  • When did PolarityTE go public?
  • Is PolarityTE in the S&P 500?
  • Is PolarityTE in the NASDAQ 100?
  • Is PolarityTE in the Dow Jones?
  • When was PolarityTE's last earnings report?
  • When does PolarityTE report earnings?
  • Should I buy PolarityTE stock now?

What is the primary business of PolarityTE?

PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

What is the ticker symbol for PolarityTE?

The ticker symbol for PolarityTE is NASDAQ:PTE

Does PolarityTE pay dividends?

No, PolarityTE does not pay dividends

What sector is PolarityTE in?

PolarityTE is in the Healthcare sector

What industry is PolarityTE in?

PolarityTE is in the Biotechnology industry

What country is PolarityTE based in?

PolarityTE is headquartered in United States

When did PolarityTE go public?

PolarityTE's initial public offering (IPO) was on 16 August 1999

Is PolarityTE in the S&P 500?

No, PolarityTE is not included in the S&P 500 index

Is PolarityTE in the NASDAQ 100?

No, PolarityTE is not included in the NASDAQ 100 index

Is PolarityTE in the Dow Jones?

No, PolarityTE is not included in the Dow Jones index

When was PolarityTE's last earnings report?

PolarityTE's most recent earnings report was on 10 November 2021

When does PolarityTE report earnings?

The date for PolarityTE's next earnings report has not been announced yet

Should I buy PolarityTE stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions